Skip to content

NARCOMEDI

Active Private limited companyfounded 2022active for 4 yearsRue des Saules 62, 1380 LasneKBO/BCE: BE 0790.342.241

Annual accounts 2025

micro format, filed on 27-07-2026, 4 days before the deadline
€142,694
▲ 40.7%
€117,075
▲ 47.6%
€94,428
▲ 65.6%
€218,736
▲ 79.9%
68.1%
▲ 12.2 percentage points
4.12
▲ 0.71

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €270,000. Estimated: probably between €230,000 and €350,000.

Balance sheet

balance sheet total €318,602 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

68.1%

Higher than 55% of 21,368 companies in 2025.

4.12

Higher than 63% of 20,917 companies in 2025.

29.6%

Higher than 65% of 21,218 companies in 2025.

NARCOMEDI Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023
Balance sheet: assets
20/58 318,602219,224147,217
21/28 29,73447,15464,574
21 1,0962,2793,462
22/27 27,89844,13560,372
23 3141,3192,324
24 27,58442,81658,048
28 740740740
29/58 288,868172,06982,643
40/41 156,76492,78763,793
41 156,76492,78763,793
54/58 132,10479,28218,850
Balance sheet: equity and liabilities
10/49 318,602219,224147,217
10/15 216,959122,53165,518
10/11 3,0003,0003,000
14 213,959119,53162,518
17/49 101,64496,69381,699
17 31,51246,23160,902
170/4 31,51246,23160,902
42/48 70,13250,46220,797
44 23,2508,859254
440/4 23,2508,859254
45 46,67541,60320,543
450/3 46,67541,60320,543
47/48 207--
Income statement
9900 142,694101,432102,837
62 6,2922,250-
630 17,42017,42018,889
640/8 1,9062,4631,717
9901 117,07579,29982,231
65/66B 2,1912,2273,170
65 2,1912,2273,170
9903 114,88577,07279,061
67/77 20,45720,06016,543
9904 94,42857,01262,518
9905 94,42857,01262,518
Appropriation of the result
9906 213,959119,53162,518
14P 119,53162,518-
Document PDFPDFPDF

The notes to these accounts have 9 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 27-07-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 27-07-2026 2026-00334234 PDF
31-12-2024 micro format 26-08-2025 2025-00424641 PDF
31-12-2023 micro format 29-07-2024 2024-00300123 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023
134,49596,719101,120
111,84874,43281,408
0083,464
52,82260,432-
218,736121,60761,846
68.1%55.9%44.5%
4.123.413.97
0.470.791.25
43.5%46.5%95.4%
29.6%26.0%42.5%
61.4043.4431.90

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item202520242023
Tangible fixed assets--€79,174
Intangible fixed assets--€3,550
Financial fixed assets--€740
€17,420€17,420€18,889

Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)

Insights on NARCOMEDI

The operating result for 2025 is 48% higher than in 2024 and the highest since 2023. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total falls from 44.1% to 31.9%. Equity and debt are higher.

Next steps